NCT01617564 is a NA clinical trial of bipuvacain in Second Trimester Medical Abortion, sponsored by Kristina Gemzell Danielsson.

Who is sponsoring NCT01617564?

NCT01617564 is sponsored by Kristina Gemzell Danielsson.

What drugs are being tested in NCT01617564?

Interventions in NCT01617564: bipuvacain, NaCl.

What condition does NCT01617564 study?

NCT01617564 studies Second Trimester Medical Abortion.

Is NCT01617564 still recruiting?

NCT01617564 is currently completed. Last updated 15 May 2015.

Last reviewed 2015-05-15 · How we verify

NCT01617564

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Paracervical Block (PCB) During II-trimester Abortion- A Randomized Controlled Trial

Completed NA Last updated 15 May 2015

What this trial tests

NA trial testing bipuvacain in Second Trimester Medical Abortion in 112 participants. Completed in 1 May 2015.

Timeline

1 May 2012

Primary endpoint
1 May 2015

1 May 2015

Quick facts

Lead sponsor	Kristina Gemzell Danielsson
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	randomized
Design	single group
Masking	triple
Primary purpose	treatment
Enrollment	112
Start date	1 May 2012
Primary completion	1 May 2015
Estimated completion	1 May 2015
Sites	2 locations across Sweden

Drugs / interventions tested

bipuvacain — full drug profile →
NaCl — full drug profile →

Conditions studied

Second Trimester Medical Abortion — all drugs for Second Trimester Medical Abortion →

Sponsor

Kristina Gemzell Danielsson — full company profile →

Who can join

Adults 18 to 50, female only, with Second Trimester Medical Abortion. Patients with the condition only — healthy volunteers not accepted.

What's being measured

Primary outcomes are the specific endpoints the trial is designed to prove or disprove.

Pain score
Time frame: at 24 hours
Pain indicated on VAS at specific time intervals during the induction to expulsion

Sponsor's own description

Paracervical blockage can reduce severe pain during second trimester induced medical abortion.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

Paracervical block as pain treatment during second-trimester medical termination of pregnancy: an RCT with bupivacaine versus sodium chloride.
Andersson IM, Benson L, Christensson K, Gemzell-Danielsson K. · · 2016 · cited 7× · PMID 26573530 · DOI 10.1093/humrep/dev286

Verify or expand the search:

Other Kristina Gemzell Danielsson trials

Trials by the same sponsor.

NCT03269357 — LARC Forward Counselling · NA · completed

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT01617564 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Kristina Gemzell Danielsson
Last refreshed: 15 May 2015

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT01617564.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing